Diversity is critical for the health of our gut, but also in science, Dr. Carolina Tropini says Dr. Carolina Tropini had never intended to study bacteria before she started her PHD; in fact, not studying bacteria was her only requirement. Like most people, she saw bacteria as dirty, infectious agents that only carry pathogens. That all changed when she heard…
Read More

An Inhaled Drug Cocktail Could Block COVID-19

The immunotherapy based on antibody research being developed by Vancouver Coastal Health Research Institute researcher Dr. Horacio Bach could provide short-term protection against the novel coronavirus, SARS-CoV-2. To date, COVID-19—a disease that largely affects the respiratory system—has claimed the lives of over 870,000 people worldwide. “One of the challenges we face with regards to a potential COVID-19 vaccine is that we…
Read More
Representatives of India and Canada expanded their existing partnership today that extends student mobility and enhances research collaborations between academia and industry. The new agreement between All India Council for Technical Education (AICTE) and Mitacs enables 30 master’s students to participate in research exchanges in Canada through Mitacs’s internship program. This opportunity allows students to gain applied research opportunities in…
Read More
Molecular biology and biochemistry professor Ly Vu is working to improve survival rates for those with acute myeloid leukemia (AML). Her research program is identifying new factors that can serve as targetable molecules and pathways to specifically eliminate leukemia cells while sparing normal cells. With $100,000 in CFI-funded infrastructure, this research will provide the scientific foundation for developing a therapy…
Read More
The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) are pleased to announce they have formed a new collaboration, “The CPDC-adMare Radiopharmaceutical Initiative (CARI)” to bring their respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain a considerable global competitive advantage: radiopharmaceuticals. This field revolutionized precision medicine by the use…
Read More
Type 1 Diabetes (T1D), once known as insulin dependent diabetes, is a chronic condition that causes pancreatic cells to produce little or no insulin. Insulin plays an important role in regulating blood sugar, or glucose, so T1D patients cannot naturally regulate their blood sugar levels. Current treatments for diabetes are costly with diabetes-related healthcare costs in Canada expected to increase…
Read More

Genomics Study Uncovers a Novel Feature of Mantle Cell Lymphoma Biology

Mantle cell lymphoma (MCL) is a rare and incurable form of B cell non-Hodgkin lymphoma. To develop effective cancer therapies for the disease, a better understanding of how MCL cells develop and persist is essential. In a new study published in the journal Blood, led by GSC Senior Scientist Dr. Ryan Morin, researchers used exome, genome and transcriptome sequencing to characterize MCL tumours and identified a novel…
Read More
A renowned British Columbia doctor is being celebrated for his pioneering work fighting HIV/AIDS with a new commemorative stamp. Dr. Julio Montaner is one of six distinguished Canadian doctors and researchers whose faces will grace the new run of stamps from Canada Post. Montaner, who moved to Vancouver from his native Argentina in 1981, is recognized for his research work that…
Read More
Reprogramming of the epigenome is a hallmark of cellular differentiation in mammals, but how the essential but distinct genomic imprints established in and oocytes remained unclear. The authors show that de novo DNA methylation, including at imprinted genes, is directed in the genome of prospermatogonia by a specific modification on the amino-terminus of histone H3, namely lysine 36 (H3K36).
Read More
AbCellera today announced that interim data from a Phase 2 clinical trial of LY-CoV555, the first antibody to emerge from AbCellera’s collaboration with Eli Lilly and Company (Lilly) to create antibody therapies for the prevention and treatment of COVID-19, shows a reduction in the rate of hospitalization in patients treated with the antibody. Key findings from the interim data of…
Read More